Biotheranostics stock
WebJan 6, 2024 · January 6, 2024 By Sean Whooley. Hologic (NSDQ: HOLX) announced that it agreed to acquire molecular diagnostic test maker Biotheranostics for approximately $230 million. Privately held, … WebJun 29, 2024 · The Breast Cancer Index test, made by Biotheranostics, analyzes the activity of 11 genes to help predict the risk of early-stage, hormone-receptor-positive breast cancer coming back 5 to 10 years after diagnosis. The test can help women and their doctors decide if extending hormonal therapy 5 more years (for a total of 10 years of …
Biotheranostics stock
Did you know?
WebFeb 23, 2024 · February 23, 2024 By Sean Whooley. Hologic (NSDQ: HOLX) announced that it completed its previously announced acquisition of Biotheranostics for $230 million. Marlborough, Mass.-based Hologic last ... WebJan 8, 2024 · Hologic, Inc. HOLX recently announced its plans to acquire Biotheranostics, Inc., a privately held commercial-stage company providing molecular diagnostic tests for …
WebJan 5, 2024 · Biotheranostics is a leader in the development of evidence-based biomarkers to address unmet medical needs, and the company has set the foundation … WebCompany profile page for BioTheranostics Inc including stock price, company news, press releases, executives, board members, and contact information
WebBiotheranostics is a molecular diagnostics company that develops and provides diagnostic, prognostic, and predictive tests that helps physicians in the treatment of cancer patients. It offers CancerTYPE ID, a gene expression test for metastatic patients with diagnostic ambiguity, and Breast Cancer Index, a tool for breast cancer patients. WebJan 5, 2024 · Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, announced today that it has agreed to acquire Biotheranostics, Inc., a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers, for approximately $230 million, subject to working capital and other customary closing …
WebBeing part of Hologic only helps bring that hope closer to reality. In addition, patients facing the challenges of metastatic cancer will have broader access to our CancerTYPE ID …
WebDec 10, 2024 · San Diego, CA, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Biotheranostics, Inc. announced today that several abstracts featuring updates on ongoing resea... solar radiation map of the navajo nationWebContact Information. 9640 Towne Centre Dr #200. San Diego, CA 92121. Visit Website. Email this Business. (877) 886-6739. solar radiation in kuwaitWebDec 8, 2024 · Biotheranostics, Inc. operates a CLIA-certified and CAP-accredited diagnostic laboratory in San Diego, California. Biotheranostics, Inc., is a leading healthcare provider in the oncology field ... solar radiation measuring devicesWebBiotheranostics, Inc. is a commercial-stage molecular diagnostics company that develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. The company is based in San Diego, CA and offers testing se rvices through its CLIA-certified, CAP-accredited laboratory that is directly ... sly data-sly-callsolar radiation panels on spacecraftWebJan 5, 2024 · SPX. +1.87%. Medical technology company Hologic Inc. HOLX, +0.71% said late Tuesday it has agreed to buy privately held Biotheranostics Inc. for $230 million. … solar radiation and measurementWebApr 19, 2024 · Biotheranostics Inc. has agreed to pay $2 million to resolve allegations that it submitted and caused the submission of false claims to Medicare for Breast Cancer Index (BCI) tests that were not reasonable and necessary for the diagnosis and treatment of breast cancer, the Department of Justice announced today. Biotheranostics is a … solar radiation map of vietnam